[1] MEZZANO G,JUANOLA A,CARDENAS A,et al.Global burden of disease:acute-on-chronic liver failure,a systematic review and meta-analysis[J].Gut,2022,71(1):148-155. [2] KARVELLAS C J,FRANCOZ C,WEISS E.Liver transplantation in acute-on-chronic liver failure[J].Transplantation,2021,105(7):1471-1481. [3] SALIBA F,BAÑARES R,LARSEN F S,et al.Artificial liver support in patients with liver failure:a modified DELPHI consensus of international experts[J].Intensive Care Med,2022,48(10):1352-1367. [4] 黄贝贝,宁玲,李文渊,等.血浆置换与双重血浆分子吸附系统单用或联合使用治疗HBV相关慢加急性肝衰竭患者预后预测模型的建立与评估[J].临床肝胆病杂志,2021,37(12):2802-2807. [5] WANG L,ZHU S,LIU Y,et al.Prognostic value of decline in model for end-stage liver disease score and hepatic encephalopathy in hepatitis B-related acute-on-chronic liver failure patients treated with plasma exchange[J].Scand J Gastroenterol,2022,57(9):1089-1096. [6] 韩成美,任运华,丁雷.COSSH-ACLF评分联合血清白细胞介素-37水平对乙型肝炎病毒相关慢加急性肝衰竭患者近期预后的评估价值[J].实用医学杂志,2021,37(4):472-476. [7] WANG J X.To use or not to use propensity score matching?[J].Pharm Stat,2021,20(1):15-24. [8] 中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊治指南(2018年版)[J].中华临床感染病杂志,2018,11(6):401-410. [9] BAJAJ J S,O’LEARY J G,LAI J C,et al.Acute-on-chronic liver failure clinical guidelines[J].Am J Gastroenterol,2022,117(2):225-252. [10] NGU N L Y,FLANAGAN E,BELL S,et al.Acute-on-chronic liver failure:Controversies and consensus[J].World J Gastroenterol,2023,29(2):232-240. [11] BR V K,SARIN S K.Acute-on-chronic liver failure:terminology,mechanisms and management[J].Clin Mol Hepatol,2023,29(3):670-689. [12] MAIWALL R,SARIN S K.Plasma exchange in acute and acute on chronic liver failure[J].Semin Liver Dis,2021,41(4):476-494. [13] 苏亚勇,徐成润,郭永木,等.慢加急性乙型肝炎肝衰竭患者死亡危险因素和预后评分模型的构建[J].实用肝脏病杂志,2021,24(3):391-394. [14] 杜菲,杨玉香,强丽,等.MELD、CTP评分及MLR联合预测人工肝治疗慢加急性肝衰竭预后的临床研究[J].重庆医学,2022,51(20):3516-3520. [15] 章颖,明芳,章幼奕,等.血清甲状腺激素、血脂水平、联合血钠的终末期肝病模型评分对血浆置换治疗慢加急性肝衰竭患者短期预后的评估价值[J].上海医学,2021,44(4):237-241. [16] YE Q X,HUANG J F,XU Z J,et al.Short-term prognostic factors for hepatitis B virus-related acute-on-chronic liver failure[J].World J Clin Cases,2022,10(23):8186-8195. [17] GOUDSMIT B F J,BRAAT A E,TUSHUIZEN M E,et al.Development and validation of a dynamic survival prediction model for patients with acute-on-chronic liver failure[J].JHEP Rep,2021,3(6):100369. [18] ZHANG Q,MAO W L,HE X,et al.High red cell distribution width-to-platelet ratio indicates adverse outcomes for hepatitis B virus-associated decompensated cirrhosis[J].Biomark Med,2023,17(4):189-196. |